» Articles » PMID: 27526195

Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter Baumannii ATCC 19606

Overview
Journal PLoS One
Date 2016 Aug 16
PMID 27526195
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The lipid A moiety of lipopolysaccharide (LPS) is the main constituent of the outer leaflet of the Gram-negative bacterial outer membrane (OM) and is essential in many Gram-negative pathogens. An exception is Acinetobacter baumannii ATCC 19606, where mutants lacking enzymes occurring early in lipid A biosynthesis (LpxA, LpxC or LpxD), and correspondingly lacking LPS, can grow. In contrast, we show here that LpxH, an enzyme that occurs downstream of LpxD in the lipid A biosynthetic pathway, is essential for growth in this strain. Multiple attempts to disrupt lpxH on the genome were unsuccessful, and when LpxH expression was controlled by an isopropyl β-d-1-thiogalactopyranoside (IPTG) inducible promoter, cell growth under typical laboratory conditions required IPTG induction. Mass spectrometry analysis of cells shifted from LpxH-induced to uninduced (and whose growth was correspondingly slowing as LpxH was depleted) showed a large cellular accumulation of UDP-2,3-diacyl-GlcN (substrate of LpxH), a C14:0(3-OH) acyl variant of the LpxD substrate (UDP-3-O-[(R)-3-OH-C14]-GlcN), and disaccharide 1-monophosphate (DSMP). Furthermore, the viable cell counts of the LpxH depleted cultures dropped modestly, and electron microscopy revealed clear defects at the cell (inner) membrane, suggesting lipid A intermediate accumulation was toxic. Consistent with this, blocking the synthesis of these intermediates by inhibition of the upstream LpxC enzyme using CHIR-090 abrogated the requirement for IPTG induction of LpxH. Taken together, these data indicate that LpxH is essential for growth in A. baumannii ATCC19606, because, unlike earlier pathway steps like LpxA or LpxC, blockage of LpxH causes accumulation of detergent-like pathway intermediates that prevents cell growth.

Citing Articles

Design and Evaluation of Pyridinyl Sulfonyl Piperazine LpxH Inhibitors with Potent Antibiotic Activity Against Enterobacterales.

Ennis A, Cochrane C, Dome P, Jeong P, Yu J, Lee H JACS Au. 2024; 4(11):4383-4393.

PMID: 39610720 PMC: 11600146. DOI: 10.1021/jacsau.4c00731.


Cerastecins inhibit membrane lipooligosaccharide transport in drug-resistant Acinetobacter baumannii.

Wang H, Ishchenko A, Skudlarek J, Shen P, Dzhekieva L, Painter R Nat Microbiol. 2024; 9(5):1244-1255.

PMID: 38649414 DOI: 10.1038/s41564-024-01667-0.


A new antibiotic traps lipopolysaccharide in its intermembrane transporter.

Pahil K, Gilman M, Baidin V, Clairfeuille T, Mattei P, Bieniossek C Nature. 2024; 625(7995):572-577.

PMID: 38172635 PMC: 10794137. DOI: 10.1038/s41586-023-06799-7.


Targeting LPS biosynthesis and transport in gram-negative bacteria in the era of multi-drug resistance.

Romano K, Hung D Biochim Biophys Acta Mol Cell Res. 2022; 1870(3):119407.

PMID: 36543281 PMC: 9922520. DOI: 10.1016/j.bbamcr.2022.119407.


Pharmacoinformatics approaches to identify potential hits against tetraacyldisaccharide 4'-kinase (LpxK) of .

Damale M, Pathan S, Patil R, Sangshetti J RSC Adv. 2022; 10(54):32856-32874.

PMID: 35516480 PMC: 9056689. DOI: 10.1039/d0ra06675c.


References
1.
Bos M, Tommassen J . Viability of a capsule- and lipopolysaccharide-deficient mutant of Neisseria meningitidis. Infect Immun. 2005; 73(9):6194-7. PMC: 1231088. DOI: 10.1128/IAI.73.9.6194-6197.2005. View

2.
Garcia-Quintanilla M, Caro-Vega J, Pulido M, Moreno-Martinez P, Pachon J, McConnell M . Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii. Antimicrob Agents Chemother. 2016; 60(8):5076-9. PMC: 4958213. DOI: 10.1128/AAC.00407-16. View

3.
Wang X, Quinn P . Lipopolysaccharide: Biosynthetic pathway and structure modification. Prog Lipid Res. 2009; 49(2):97-107. DOI: 10.1016/j.plipres.2009.06.002. View

4.
Metzger 4th L, Raetz C . An alternative route for UDP-diacylglucosamine hydrolysis in bacterial lipid A biosynthesis. Biochemistry. 2010; 49(31):6715-26. PMC: 2914816. DOI: 10.1021/bi1008744. View

5.
Metzger 4th L, Lee J, Finer-Moore J, Raetz C, Stroud R . LpxI structures reveal how a lipid A precursor is synthesized. Nat Struct Mol Biol. 2012; 19(11):1132-8. PMC: 3562136. DOI: 10.1038/nsmb.2393. View